Antineutrophil cytoplasmic antibodies in childhood systemic lupus erythematosus. 1998

A Bakkaloglu, and R Topaloglu, and U Saatçi, and S Ozdemir, and S Ozen, and Y Başsoy, and N Beşbaş
Department of Pediatric Nephrology and Rheumatology, Hacettepe University, School of Medicine, Ankara, Turkey.

We aimed to evaluate the presence of peripheral antineutrophil cytoplasmic antibodies (p-ANCA) and cytoplasmic antineutrophil cytoplasmic antibodies (c-ANCA) in children with SLE and to correlate its association of laboratory findings. Twenty-one children with SLE were studied. Serum samples in patients were tested by indirect immunofluorescence (IIF) slide kit (INOVA) for c-ANCA and p-ANCA and by ELISA for myeloperoxidase (MPO-ANCA) and proteinase 3 (PR3-ANCA). All the patients but two were quiescent for lupus at the time of sampling. Sixteen of 21 patients showed positive IIF staining whereas only 5 had MPO-ANCA and 2 of nine PR3-ANCA. The data suggests that SLE may be associated p-ANCA directed against additional target antigens rather than MPO and may be implicated in the pathogenesis of SLE or may be only non-specific antibodies developed in lupus.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity

Related Publications

A Bakkaloglu, and R Topaloglu, and U Saatçi, and S Ozdemir, and S Ozen, and Y Başsoy, and N Beşbaş
November 1999, The Journal of rheumatology,
A Bakkaloglu, and R Topaloglu, and U Saatçi, and S Ozdemir, and S Ozen, and Y Başsoy, and N Beşbaş
September 1994, The Journal of rheumatology,
A Bakkaloglu, and R Topaloglu, and U Saatçi, and S Ozdemir, and S Ozen, and Y Başsoy, and N Beşbaş
January 1992, Contributions to nephrology,
A Bakkaloglu, and R Topaloglu, and U Saatçi, and S Ozdemir, and S Ozen, and Y Başsoy, and N Beşbaş
July 1996, British journal of rheumatology,
A Bakkaloglu, and R Topaloglu, and U Saatçi, and S Ozdemir, and S Ozen, and Y Başsoy, and N Beşbaş
January 2002, Clinical and experimental dermatology,
A Bakkaloglu, and R Topaloglu, and U Saatçi, and S Ozdemir, and S Ozen, and Y Başsoy, and N Beşbaş
January 2003, Lupus,
A Bakkaloglu, and R Topaloglu, and U Saatçi, and S Ozdemir, and S Ozen, and Y Başsoy, and N Beşbaş
January 1995, European journal of pediatrics,
A Bakkaloglu, and R Topaloglu, and U Saatçi, and S Ozdemir, and S Ozen, and Y Başsoy, and N Beşbaş
May 1995, Arthritis and rheumatism,
A Bakkaloglu, and R Topaloglu, and U Saatçi, and S Ozdemir, and S Ozen, and Y Başsoy, and N Beşbaş
November 1996, The Journal of rheumatology,
A Bakkaloglu, and R Topaloglu, and U Saatçi, and S Ozdemir, and S Ozen, and Y Başsoy, and N Beşbaş
January 2021, Case reports in rheumatology,
Copied contents to your clipboard!